MG
RGEN icon

Marex Group’s Repligen RGEN Stock Holding History

Marex Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,572
Closed -$656K – 1311
2026
Q1 		$656K Buy
+5,572
New +$778K ﹤0.01% 552

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Marex Group's RGEN Position: Q2 2026 in Review

Marex Group sold out of Repligen (RGEN) in Q2 2026, closing a stake of 5,572 shares — an estimated $656K sold.

Marex Group first reported a position in RGEN in Q1 2026 and held it in 1 quarter. The position peaked at $656K in Q1 2026. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Marex Group reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Marex Group sold 5,572 Repligen shares in Q2 2026, an estimated $656K.
  • Marex Group first reported a position in Repligen in Q1 2026 and held it in 1 quarter.
  • Marex Group's Repligen position peaked at $656K in Q1 2026.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.